- Home
- MYNZ
MYNZ
Mainz Biomed N.V.
as 06-27-2025 4:00pm EST
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
| Founded: | 2021 | Country: | Germany |
| Employees: | N/A | City: | N/A |
| Market Cap: | 5.5M | IPO Year: | 2021 |
| Target Price: | $14.00 | AVG Volume (30 days): | 118.7K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -22.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.34 - $22.40 | Next Earning Date: | 07-07-2025 |
| Revenue: | $893,991 | Revenue Growth: | -0.17% |
| Revenue Growth (this year): | 26.06% | Revenue Growth (next year): | 4.97% |
Latest Mainz Biomed N.V. News
MYNZ Breaking Stock News: Dive into MYNZ Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test
Medical Device Network
18 days ago
Mainz begins next phase of project to develop pancreatic cancer blood test
GlobeNewswire
18 days ago
Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
GOBankingRates
a month ago
7 Summer Side Hustles That Can Pay $1,000 a Week or More
Yahoo Finance Video
a month ago
Will Tesla have to play catch up to Waymo's robotaxis?
Yahoo Finance
a month ago
Why Scott Bessent wants to make it easier for banks to own Treasurys
The Guardian
a month ago
When are people too old to do their jobs?
GlobeNewswire
a month ago
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
Compare MYNZ vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MYNZ Mainz Biomed N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.